Neurological outcomes 1 year after COVID-19 diagnosis: A prospective longitudinal cohort study.
Verena RassRonny BeerAlois Josef SchiefeckerAnna LindnerMario KoflerBogdan-Andrei IanosiPhilipp MahlknechtBeatrice HeimMarina PeballFederico CarboneVictoria LimmertPhilipp KindlLauma PutninaElena FavaSabina SahanicThomas SonnweberWolfgang N LöscherJulia V WanschitzMarie-Theres PertlAtbin DjamshidianIvan TancevskiGünter WeissRosa Bellmann-WeilerStefan KiechlKlaus SeppiJudith Loeffler-RaggBettina PfauslerRaimund HelbokPublished in: European journal of neurology (2022)
Our data indicate that a significant patient number still suffer from neurological sequelae including neuropsychiatric symptoms 1 year after COVID-19 calling for interdisciplinary management of these patients.
Keyphrases
- coronavirus disease
- sars cov
- end stage renal disease
- ejection fraction
- newly diagnosed
- prognostic factors
- electronic health record
- cross sectional
- metabolic syndrome
- adipose tissue
- patient reported outcomes
- cerebral ischemia
- depressive symptoms
- weight loss
- blood brain barrier
- deep learning
- sleep quality
- data analysis